Indonesia is the fourth most populous country in the world — 270 million people, a growing middle class, and a medical device market that's been expanding faster than most markets in the region for the better part of a decade. It's also one of the more complex regulatory environments for foreign manufacturers trying to get in.
BPOM — Badan Pengawas Obat dan Makanan, the national food and drug authority — manages medical device registration alongside pharmaceuticals, food, and cosmetics. If your company is thinking about Indonesia or already has product there, understanding how BPOM works (and how it sometimes doesn't) is kind of non-negotiable.
This isn't a comprehensive registration guide — for that, you need a local regulatory consultant. What this is: a practical overview of the pieces that catch people off guard, and how to research the existing landscape before you commit time and money to a filing.
What BPOM actually oversees
BPOM's mandate covers medical devices, in vitro diagnostics, and health products — a broader scope than some other Asian food and drug agencies. They operate under the Ministry of Health but with significant independent authority. Regulations have evolved quite a bit over the past several years, particularly with the implementation of Government Regulation No. 5 of 2021 and subsequent BPOM-level technical guidance. So if you're working from information that's more than two or three years old, it's worth checking what's changed.
Enforcement is the part of BPOM that gets less attention in market entry planning — and probably shouldn't. BPOM conducts market surveillance and has the authority to pull products that are distributed without registration or with lapsed registrations. The consequence isn't just a fine. Your local distributor's import license is at risk. That changes how seriously you need to take registration status tracking.
The classification system: Class A through D
Indonesia classifies medical devices into four risk-based classes. The classification determines your documentation requirements and your review timeline. Here's the framework:
| Class | Risk | Typical devices | Official review timeline |
|---|---|---|---|
| Class A | Low | Non-sterile bandages, tongue depressors, examination gloves | 45 working days |
| Class B | Medium-low | Syringes, blood pressure monitors, surgical drapes, contact lenses | 60 working days |
| Class C | Medium-high | Infusion pumps, powered surgical instruments, continuous glucose monitors | 90 working days |
| Class D | High | Active implantables, heart valves, neurostimulators | 90 working days |
A few things to understand about those timelines. They're calendar-based working days, which already means they're longer in practice. More importantly, they measure BPOM's review period — not the total time from application submission to having a registration number in hand. If your submission has deficiencies (missing documents, incomplete translations, questions about your technical file), the clock pauses and you restart from where you left off after resolving the issue. That can add weeks or months easily.
The practical timeline that experienced RA consultants quote for Class C and D devices is typically 12-24 months from initial submission for a company that's doing this for the first time. Class A and B can be faster, but "45 working days" is the floor, not the average.
The thing people miss: the local importer requirement
This is probably the most important structural difference between BPOM and some other markets. Foreign manufacturers cannot hold BPOM registrations directly.
Every medical device registration in Indonesia must be held by a local Indonesian importer — a company registered with BPOM as an authorized importer/distributor. That local entity is the license holder. They are, legally, the party responsible for the product in the Indonesian market.
Why does this matter beyond the obvious complexity of needing a local partner before you can register? A few reasons:
First, when you search the BPOM database, you'll often see an Indonesian company name where you'd expect to see the manufacturer. "PT Xyz Distribution" holds 50 registrations, and figuring out which foreign OEMs those represent requires additional research. This is something we try to surface in Meridian Trace — inferring the underlying OEM where we can identify it from product names, cross-market registrations, or other signals.
Second, the registration belongs to the local importer. If your relationship with your distributor goes sideways, the registration doesn't automatically follow you to a new partner. You either need to negotiate the transfer (which requires the original license holder's cooperation) or file new registrations with your new importer, which restarts the clock. This should be addressed explicitly in any distribution agreement — specifically, what happens to the registrations if the relationship terminates.
Third, the local importer's license status affects your registration's validity. If BPOM suspends or revokes your distributor's import authorization, your product registrations can be affected even if the products themselves have no issues.
Documentation basics
BPOM requires a technical dossier for the device, proof of the manufacturer's quality management system (ISO 13485 certification, typically), and evidence of market authorization in the country of origin. That last requirement — the country of origin authorization — is meaningful for companies selling in Indonesia before they're registered in their home market, which sometimes happens with startup device companies.
Everything needs to be in Indonesian, or accompanied by a certified Indonesian translation. The translation requirement is one of the more underestimated costs in the process. Technical documents for Class C and D devices can be extensive, and certified translation isn't cheap.
Clinical evidence requirements scale with device class. Class A and B devices typically rely on literature and predicate device comparisons. Class C and D devices often require clinical data, particularly if there's no established substantial equivalence pathway available.
How to check registration status
BPOM has a public registration lookup at their official portal (cekbpom.pom.go.id). It works, but it's built for looking up individual products — not for doing research across many products or manufacturers.
If you want to understand what's registered in Indonesia in a specific product category, or what registrations a specific manufacturer holds, or which registrations are active versus lapsed, the BPOM portal is going to give you a slow and manual experience. That's what Meridian Trace is for — we've indexed the same underlying data with search and filter capability across all product categories and across our other seven Asian markets simultaneously.
Search Indonesia's BPOM registration database
See who's registered in your product category, what your competitors hold, and which registrations are active versus lapsed. 50 free searches per month.
Start searching free →Common mistakes worth knowing about
Underclassifying the device. Companies sometimes classify at Class B when BPOM would classify at Class C. The incentive is obvious — faster review, less documentation burden. But BPOM catches this during review, rejects the submission, and you start over with the correct class. Net result: more time lost than if you'd filed correctly from the start.
Not having ISO 13485 in place. If your QMS certification isn't current when you file, that's a problem. BPOM will ask for it. The certificate needs to cover the specific device you're registering.
Not locking in the distributor contract terms around registration transfers before signing. This one shows up after the fact. See the local importer section above.
Treating the BPOM online system as reliable for tracking application status. It's gotten better, but Indonesian RA consultants will tell you to maintain your own tracking and follow up directly rather than relying on portal status updates being current.
Registration validity and renewal
BPOM registrations are valid for five years from the date of issuance. Renewal applications should be submitted at least six months before the expiry date. If you let a registration lapse, your local importer cannot legally import new stock — though existing stock already in the country can typically continue to be sold for a grace period while the renewal is processed.
Tracking registration expiry dates across a product portfolio in multiple markets is one of those things that sounds manageable until it isn't. A five-year validity means the registrations you filed in 2021 come due in 2026. If you're managing a portfolio of 20 products, some with multiple local distributors in Indonesia, that's a non-trivial tracking problem.
The bottom line
Indonesia is a market worth taking seriously — the volume is there, the demographics are favorable, and the demand for medical devices is growing. The regulatory process is more complex than some neighboring markets, and the local importer structure adds dynamics that don't exist in Singapore or Japan. But none of that complexity is insurmountable. What it requires is starting earlier than you think you need to, having a competent local RA consultant, and understanding the contract implications of the distributor relationship before you sign anything.
For the research side — understanding who's already in the market, what's registered in your category, and what your competitors hold — that's what databases are for.